跳至主要内容
临床试验/ACTRN12622000696796
ACTRN12622000696796已完成未知

Evaluation of the synergistic effect of a new probiotic concept and octacosanol in the treatment of obesity and associated comorbidities in overweight and obese women

Faculty of Pharmacy, University of Belgrade0 个研究点目标入组 55 人开始时间: 2022年5月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
55

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
Female

入选标准

  • Overweight and obese women (body mass index > 25 kg/m^2) with or without other comorbidities (hypertension, dyslipidemia,hyperglycemia and/or insulin resistance)

排除标准

  • Chronic disease of the kidneys, thyroid gland and gastrointestinal tract (Crohn's disease, ulcerative colitis)
  • Taking antibiotic therapy in the last month
  • Age under 18 years
  • Taking probiotic and/or prebiotic dietary supplements
  • Hypersensitivity/intolerance to any ingredient of the product
  • Pregnancy or breast-feeding

研究者

发起方
Faculty of Pharmacy, University of Belgrade

相似试验